Risk factors for the development of macular edema in children with uveitis.

children complications macular edema risk factors uveitis

Journal

Frontiers in ophthalmology
ISSN: 2674-0826
Titre abrégé: Front Ophthalmol (Lausanne)
Pays: Switzerland
ID NLM: 9918419176106676

Informations de publication

Date de publication:
2023
Historique:
received: 29 12 2022
accepted: 17 05 2023
medline: 2 6 2023
pubmed: 2 6 2023
entrez: 10 7 2024
Statut: epublish

Résumé

To determine the risk factors for macular edema (ME) in children with uveitis. A retrospective study was conducted of 150 pediatric patients (264 eyes) with uveitis attending 2 tertiary medical centers. Data were collected from the medical files on demographics, type of uveitis, etiology, clinical findings, treatment, and time to development of ME. Risk factors for the development of ME were identified. ME developed in 63 eyes (23.9%) over a mean period of 15.3 ± 2.95 months from diagnosis of uveitis, at a rate of 0.08 eyes per eye-year. On univariate analysis, risk factors for the development of ME were the non-anterior location of the inflammation ( Within the pediatric population with uveitis, non-anterior location is associated with the highest risk of ME, followed by the presence of complications, such as band keratopathy and posterior synechiae. These findings indicate a need for close follow-up in children with uveitis for early detection of ME.

Identifiants

pubmed: 38983006
doi: 10.3389/fopht.2023.1134077
pmc: PMC11182263
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1134077

Informations de copyright

Copyright © 2023 Friling, Berliner, Eiger-Moscovich, Chen, Tomkins-Netzer and Kramer.

Déclaration de conflit d'intérêts

MK - Bionanism, consult; Abbvie and Jansen – lectures not related to this study. The other authors report no conflict of interest.

Auteurs

Ronit Friling (R)

Unit of Pediatric Ophthalmology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ori Berliner (O)

Department of Ophthalmology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.

Maya Eiger-Moscovich (M)

Department of Ophthalmology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.

Yi-Hsing Chen (YH)

Moorfields Eye Hospital, Institute of Ophthalmology, University College London, London, United Kingdom.

Oren Tomkins-Netzer (O)

Moorfields Eye Hospital, Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Ophthalmology, Lady Davis Carmel Medical Center, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Michal Kramer (M)

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.

Classifications MeSH